Australia's most trusted
source of pharma news
Monday, 01 December 2025
Posted 1 December 2025 AM
MSD will take over the supply of its vaccines in Australia starting from 1 January 2026, ending a four-decade long collaboration with CSL Seqirus.
The move sees MSD become responsible for the supply and distribution in Australia of its pneumococcal vaccine PneumoVax 23, as well as its HPV vaccine, Gardasil 9.

Please click the button to indicate that the printout of this article is for your personal use only and not for any type of redistribution.
Redistribution of the whole or part of Pharma in Focus by any means is a breach of copyright law.